Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk--primary results from the phase 2 YUKAWA study.
Hirayama A, Honarpour N, Yoshida M, Yamashita S, Huang F, Wasserman SM, Teramoto T. Hirayama A, et al. Among authors: yoshida m. Circ J. 2014;78(5):1073-82. doi: 10.1253/circj.cj-14-0130. Epub 2014 Mar 21. Circ J. 2014. PMID: 24662398 Free article. Clinical Trial.
Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia.
Yamashita S, Masuda D, Akishita M, Arai H, Asada Y, Dobashi K, Egashira K, Harada-Shiba M, Hirata K, Ishibashi S, Kajinami K, Kinoshita M, Kozaki K, Kuzuya M, Ogura M, Okamura T, Sato K, Shimano H, Tsukamoto K, Yokode M, Yokote K, Yoshida M. Yamashita S, et al. Among authors: yoshida m. J Atheroscler Thromb. 2020 Nov 1;27(11):1246-1254. doi: 10.5551/jat.CR004. Epub 2020 Aug 28. J Atheroscler Thromb. 2020. PMID: 32863291 Free PMC article. No abstract available.
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: yoshida m. Circ J. 2012;76(1):221-9. doi: 10.1253/circj.cj-11-0887. Epub 2011 Nov 16. Circ J. 2012. PMID: 22094911 Free article. Clinical Trial.
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification For Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: yoshida m. Circ J. 2013;77(6):1526-33. doi: 10.1253/circj.cj-12-1149. Epub 2013 Mar 14. Circ J. 2013. PMID: 23486191 Free article. Clinical Trial.
Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysis.
Daida H, Nohara R, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Daida H, et al. Among authors: yoshida m. J Atheroscler Thromb. 2014;21(7):739-54. doi: 10.5551/jat.19109. Epub 2014 Jun 20. J Atheroscler Thromb. 2014. PMID: 24953046 Free article. Clinical Trial.
Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study.
Yokoi H, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yoshida M. Yokoi H, et al. Among authors: yoshida m. Int Heart J. 2014;55(2):146-52. doi: 10.1536/ihj.13-216. Epub 2014 Mar 14. Int Heart J. 2014. PMID: 24632963 Free article. Clinical Trial.
11,159 results
You have reached the last available page of results. Please see the User Guide for more information.